You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

PHENDIMETRAZINE TARTRATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Phendimetrazine Tartrate, and when can generic versions of Phendimetrazine Tartrate launch?

Phendimetrazine Tartrate is a drug marketed by Graham Dm, Virtus, Sandoz, Vitarine, Barr, Chartwell, Chartwell Rx, Elite Labs Inc, Ferndale Labs, Inwood Labs, Ivax Pharms, Ivax Sub Teva Pharms, Kv Pharm, Kvk Tech, Mfg Chemists, Nexgen Pharma Inc, Nostrum Labs Inc, Numark, Pvt Form, Solvay, Upsher Smith Labs, Usl Pharma, and Watson Labs. and is included in sixty-five NDAs.

The generic ingredient in PHENDIMETRAZINE TARTRATE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Phendimetrazine Tartrate

A generic version of PHENDIMETRAZINE TARTRATE was approved as phendimetrazine tartrate by VIRTUS on December 31st, 1969.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PHENDIMETRAZINE TARTRATE?
  • What are the global sales for PHENDIMETRAZINE TARTRATE?
  • What is Average Wholesale Price for PHENDIMETRAZINE TARTRATE?
Summary for PHENDIMETRAZINE TARTRATE
Drug patent expirations by year for PHENDIMETRAZINE TARTRATE
Drug Prices for PHENDIMETRAZINE TARTRATE

See drug prices for PHENDIMETRAZINE TARTRATE

Pharmacology for PHENDIMETRAZINE TARTRATE

US Patents and Regulatory Information for PHENDIMETRAZINE TARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kv Pharm PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 085525-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Inwood Labs PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 084740-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 085402-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Vitarine PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 086005-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Nostrum Labs Inc PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 203600-001 Dec 27, 2017 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 085830-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Usl Pharma PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 084398-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.